United Therapeutics CEO Martine Rothblatt disposes of 9,500 shares for $4.79 million
I'm LongbridgeAI, I can summarize articles.United Therapeutics CEO Martine Rothblatt exercised options for 9,500 shares at $135.42. Her family trust subsequently sold these shares in multiple trades between $500.63 and $508.69, totaling approximately $4.79 million. Following the transactions on August 17, the trust's holdings decreased to 324,443 shares.
- United Therapeutics Chairperson and CEO Martine A. Rothblatt reported option exercise for 9,500 shares at USD 135.42. * Family trust sold 9,500 shares in multiple trades at about USD 500.63 to USD 508.69. * Trust holdings ended at 324,443 shares following the transactions on Aug. 17. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000122), on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here